[go: up one dir, main page]

PT975327E - Uso de antagonistas de 5ht3 para estimular a lavagem intestinal - Google Patents

Uso de antagonistas de 5ht3 para estimular a lavagem intestinal

Info

Publication number
PT975327E
PT975327E PT98922759T PT98922759T PT975327E PT 975327 E PT975327 E PT 975327E PT 98922759 T PT98922759 T PT 98922759T PT 98922759 T PT98922759 T PT 98922759T PT 975327 E PT975327 E PT 975327E
Authority
PT
Portugal
Prior art keywords
antagonists
stimulate intestinal
intestinal washing
washing
stimulate
Prior art date
Application number
PT98922759T
Other languages
English (en)
Inventor
Antonius Adrianus Hendr Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT975327E publication Critical patent/PT975327E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98922759T 1997-04-18 1998-04-14 Uso de antagonistas de 5ht3 para estimular a lavagem intestinal PT975327E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201149 1997-04-18

Publications (1)

Publication Number Publication Date
PT975327E true PT975327E (pt) 2003-11-28

Family

ID=8228223

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98922759T PT975327E (pt) 1997-04-18 1998-04-14 Uso de antagonistas de 5ht3 para estimular a lavagem intestinal

Country Status (12)

Country Link
US (2) US6235745B1 (pt)
EP (1) EP0975327B1 (pt)
JP (1) JP2001523239A (pt)
KR (1) KR100529512B1 (pt)
AT (1) ATE243993T1 (pt)
AU (1) AU745361B2 (pt)
CA (1) CA2286076C (pt)
DE (1) DE69816060T2 (pt)
DK (1) DK0975327T3 (pt)
ES (1) ES2202855T3 (pt)
PT (1) PT975327E (pt)
WO (1) WO1998047481A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090638A1 (en) * 1999-10-08 2001-04-11 Sanofi-Synthelabo Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
EP1347779A2 (en) * 2000-11-24 2003-10-01 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
RU2229882C2 (ru) * 2002-04-05 2004-06-10 Научно-производственный центр "Фармзащита" Лекарственное средство
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
HK1080074A1 (zh) * 2002-10-01 2006-04-21 Johnson & Johnson Pharmaceutical Research & Development, Inc. 作为酪氨酸蛋白激酶抑制剂的4，6-二氨基取代-2-[氧基或氨氧基]-[1，3，5]三嗪
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
NZ541009A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating nausea, vomiting, retching or any combination thereof
NZ541008A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
AU2004227945B2 (en) * 2003-04-04 2006-10-26 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
JPWO2005099698A1 (ja) * 2004-04-15 2008-03-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定化された４−アミノ−５−クロロ−Ｎ−［（１Ｒ，３ｒ，５Ｓ）−８−メチル−８−アザビシクロ［３．２．１］オクタ−３−イル］−２−［１−メチルブタ−２−インイルオキシ］ベンズアミド含有組成物
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) * 2005-08-12 2007-02-22 Ctg Pharma S.R.L. Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
JP2009504740A (ja) * 2005-08-16 2009-02-05 シンタ ファーマシューティカルズ コーポレーション ビス（チオ−ヒドラジドアミド）製剤
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
WO2008019363A2 (en) 2006-08-07 2008-02-14 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5ht3 modulators
NZ574756A (en) 2006-08-07 2011-03-31 Albany Molecular Res Inc 2-aminobenzoxazole carboxamides as 5ht3 modulators
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP6441890B2 (ja) 2013-03-15 2018-12-19 ブレインツリー・ラボラトリーズ，インコーポレイテッド 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
US10172833B2 (en) 2015-08-11 2019-01-08 Insys Development Company, Inc. Sublingual ondansetron spray
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
WO2020067456A1 (ja) * 2018-09-28 2020-04-02 武田薬品工業株式会社 複素環化合物
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB893267A (en) * 1958-11-25 1962-04-04 Sterling Drug Inc Laxative enemas
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
TW294595B (pt) * 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
WO1996014071A1 (es) * 1994-11-04 1996-05-17 Legarda Ibanez Juan Jose Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US6103734A (en) 1994-11-04 2000-08-15 Legarda Ibanez; Juan Jose Drug combination as a medicament to suppress the dependence of individuals to opiates
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
CA2286076A1 (en) 1998-10-29
US20010020025A1 (en) 2001-09-06
JP2001523239A (ja) 2001-11-20
KR20000075858A (ko) 2000-12-26
ATE243993T1 (de) 2003-07-15
EP0975327A1 (en) 2000-02-02
US6555546B2 (en) 2003-04-29
DE69816060T2 (de) 2004-04-22
CA2286076C (en) 2006-12-12
DK0975327T3 (da) 2003-10-20
AU745361B2 (en) 2002-03-21
AU7528298A (en) 1998-11-13
ES2202855T3 (es) 2004-04-01
DE69816060D1 (de) 2003-08-07
EP0975327B1 (en) 2003-07-02
US6235745B1 (en) 2001-05-22
KR100529512B1 (ko) 2005-11-22
WO1998047481A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
PT975327E (pt) Uso de antagonistas de 5ht3 para estimular a lavagem intestinal
TR200000782T2 (tr) Resorsinol türevleri.
ES2154741T3 (es) Uso de agentes de union a cd23 en el tratamiento de enfermedades autoinmunes.
DK0880523T3 (da) Pyrazolopyrimidiner som CRF-receptorantagonister
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
NO20012948L (no) Hydroksydifenylureasulfonamider som IL-8 reseptor antagonister
IS6388A (is) EP4 viðtaka valvís gerandefni í meðhöndluninni á beingisnun
BR0007864A (pt) Composto, e, uso de um composto
AR016981A2 (es) Polipeptidos sinteticos
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
BR9909486A (pt) Compostos calcilìticos
DE69804198D1 (de) Zementschlamm für die zementierung von bohrlöchern insbesondere ölbohrlöchern
TR200102742T2 (tr) Rezorsinol türevleri
BR9807888B1 (pt) sabÕes lÍquidos, bem como uso de triclocarbano.
ES2175246T3 (es) Reticulante pobre en reversion.
DK0788474T3 (da) Nitrobenzamider, der er anvendelige som antiarrytmiske midler
AR005704A1 (es) Heteroariloxazolidinonas
DE69727452D1 (de) Faltenbalgartiger, zylindrischer Körper
BR9200979A (pt) Cilindro misturador,especialmente para borracha
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
ES2178111T3 (es) Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno.
ES1006032Y (es) Cilindro de ventilador para aparatos de uso personal.
ES2061445T3 (es) Un procedimiento para la preparacion de una omega-alquil-amino-tetrahidro-6h-1,3-tiazin-6-ona aromatica.
KR980004002U (ko) 내부 조직상태를 확인할수 있도록 한 p.v.c 호스